BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023

Go back to BioXcel Therapeutics Reports Financial Results for the Fourth Quarter and Full Year 2023
(NASDAQ: BTAI) Delayed: 1.26 +0.06 (5.00%)
Previous Close $1.20    52 Week High
Open $1.20    52 Week Low
Day High $1.28    P/E N/A 
Day Low $1.20    EPS
Volume 203,491